Treatment · August 8, 2026
Eli Lilly Expands Early Access to Retatrutide for Severely Obese Patients
Eli Lilly provides early access to an innovative weight loss drug for patients, offering hope before formal FDA approval....
Treatment · March 29, 2026
New Triple Action Weight Loss Drug Shows Promise in Advanced Trials
An experimental weight loss drug shows transformative potential for patients seeking new treatment options....
Treatment · March 22, 2026
FDA Approves Higher-Dose Semaglutide for Weight Management Following Accelerated Review
Higher-dose semaglutide receives FDA approval through accelerated review, expanding treatment options....